SPRY1 and medullary thyroid gland carcinoma: In a study by Macia et al.[6], the expression of Spry1 reportedly restrained the proliferation of the human medullary thyroid carcinoma cell line TT in vitro and significantly inhibited tumor growth in the murine xenografts.